Cargando…
Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
BACKGROUND: The effects of insulin on cardiomyocytes, such as positive inotropic action and glucose uptake are well described. However, in vitro studies comparing long-acting insulin analogues with regard to cardiomyocyte signalling and function have not been systematically conducted. METHODS: Insul...
Autores principales: | Hartmann, Thorsten, Overhagen, Sabrina, Ouwens, D. Margriet, Raschke, Silja, Wohlfart, Paulus, Tennagels, Norbert, Wronkowitz, Nina, Eckel, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946153/ https://www.ncbi.nlm.nih.gov/pubmed/27422524 http://dx.doi.org/10.1186/s12933-016-0410-9 |
Ejemplares similares
-
Metabolic effect and receptor signalling profile of a non-metabolisable insulin glargine analogue
por: Werner, Ulrich, et al.
Publicado: (2014) -
Glargine and degludec: Solution behaviour of higher dose synthetic insulins
por: Adams, Gary G., et al.
Publicado: (2017) -
Adipo-Myokines: Two Sides of the Same Coin—Mediators of Inflammation and Mediators of Exercise
por: Raschke, Silja, et al.
Publicado: (2013) -
Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2
por: Pierre-Eugene, Cécile, et al.
Publicado: (2012) -
Degludec: the new ultra-long insulin analogue
por: Tambascia, Marcos Antonio, et al.
Publicado: (2015)